PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Peritoneal M2 macrophage transplantation as a potential cell therapy for enhancing renal repair in acute kidney injury.

Mouse / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 32004417 ↗2020Reported benefit

Peritoneal M2 macrophage transplantation as a potential cell therapy for enhancing renal repair in acute kidney injury.

MouseIschaemia-reperfusionRenalC57BL/6MaleDirect injection into the renal cortexMacrophage suspension in 50 uL phosphate-buffered saline in…

Model: Renal ischaemia-reperfusion acute kidney injury produced by bilateral renal artery (pedicle) occlusion for 30 min followed by reperfusion

Peritoneal M2 macrophages alleviated renal injury and the inflammatory response after ischaemia-reperfusion injury and promoted proximal tubular epithelial cell proliferation both in vivo and in vitro, supporting M2 macrophage transplantation as a candidate cell therapy for acute kidney injury.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.